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Cystic fi brosis is the most common genetic disorder affecting the white population. This autosomal recessive disease is caused by a mutation in the gene for the protein cystic fi brosis transmembrane conductance regulator (CFTR) found on chromosome 7. CFTR is located in epithelial cells of the airway, gastrointestinal tract, sweat glands, and genitourinary system. The CFTR gene mutation causes a defi ciency of chloride ion secretion, which leads to sodium retention and fl uid absorption causing increased viscosity of luminal secretions manifesting as malfunction of electrolyte transport (Figure 1). This presents as multiorgan system exocrine abnormalities. Manifestations of this disease include sinusitis, nasal polyps, recurrent lung infections, chronic lung disease, bowel obstruction, pancreatic insuffi ciency, and infertility. Radiologists play a key role in diagnosing and monitoring disease progression in patients with cystic fi brosis.

Sinonasal Manifestations
The prevalence of rhinosinusitis in patients with cystic fi brosis borders on 100%. 1 Viscous secretions impair mucociliary clearance, leading to infection and inflammation. Nasal polyps may be identifi ed on endoscopic evaluation in up to 86% of patients with cystic fi brosis. The most frequent fi ndings on CT are nonspecifi c and include bilateral medial displacement of the lateral nasal wall and uncinate process demineralization ( Figure 2 ).
The prevalence of rhinosinusitis in patients with cystic fi brosis approaches 100%.
Pulmonary Manifestations
Abnormal chloride transport causes thick viscous secretions with reduced mucociliary clearance, which in turn causes airway obstruction and recurrent infections. Infl ammation of the airways causes gas trapping that leads to hyperinfl ated lungs, the earliest pulmonary radiographic fi nding with or without atelectasis. Airways become fi lled with thick, viscous mucus causing mucoid impaction, which has a "fi nger-inglove" appearance ( Figure 3 ). Cystic fi brosis is characterized by recurrent infections, and it ha s an upper lobe predominance. Colonization occurs with bacteria such as Haemophilus infl uenzae, Staphylococcus aureus, Pseudomonas aeruginosa, and Burkholderia cepacia complex.
The earliest pulmonary radiographic fi nding of cystic fi brosis is hyperinfl ated lungs.
Chronic infl ammation of the airways leads to progressive irreversible dilatation of the main bronchus or bronchi (bronchiectasis). The diameter of the normal bronchus should measure approximately 0.65 to 1.0 times that of the adjacent pulmonary artery branch. Bronchiectasis causes a bronchoarterial Up to 10% of patients with cystic fibrosis eventually develop bronchopulmonary aspergilloma, a fungal infection. An aspergilloma is a ball of fungus that colonizes pulmonary scars or cavities from prior lung infections and is caused most commonly by the Aspergillus fumigatus organism (Figure 8 ). An aspergilloma may remain stable for years.
Lung transplantation is a complex, high-risk, potentially life-saving therapy for end-stage lung disease in patients with cystic fi brosis. Median survival after transplantation is 4.3 years. 2 Complications of lung transplantation include reimplantation response, acute rejection, infection, airway stenosis (Figure 9 ), posttransplantation lymphoproliferative disorder, and bronchiolitis obliterans. Early mortality most frequently is due to infection. Late complications usually are attributed to chronic rejection or bronchiolitis obliterans.
Gastrointestinal Manifestations
Gastrointestinal (GI) manifestations range from obstructive diseases such as meconium ileus and intussusception to an increased risk of Crohn disease. 3 Approximately 15% to 20% of infants with cystic fi brosis present with distal small bowel intestinal obstruction secondary to meconium ileus. 4 This finding is the earliest GI manifestation of cystic fi brosis, which occurs because of abnormally thick inspissated meconium. Contrast enema with a water-soluble contrast medium is often diagnostic and therapeutic, demonstrating a microcolon (unused colon due to impaired passage of succus entericus) and a dilated terminal ileum containing fi lling defects representing impacted meconium (Figure 10 ). Complications of meconium ileus include volvulus, bowel necrosis, perforation, meconium peritonitis, and meconium pseudocyst formation.
GI manifestations of cystic fi brosis range from meconium ileus and intussusception to an increased risk of Crohn disease. Distal intestinal obstruction syndrome is the meconium ileus equivalent in older children and adults, occurring mainly in the second and third decades of life. It is seen in up to 10% to 15% of patients with cystic fi brosis. 5 Bowel obstruction occurs in the distal ileum and right colon. Causes are hypothesized to be secondary to inspissated secretions, pancreatic insuffi ciency, undigested food residue, disordered intestinal motility, fecal stasis, and dehydration. Treatment usually is conservative and may include a therapeutic water-soluble (Gastrografi n) enema.
Pancreatic Manifestations
Cystic fi brosis represents the most common cause of inherited pancreatic insuffi ciency. This manifestation most often presents as exocrine insuffi ciency, with endocrine insufficiency less frequently. Fat deposition in the pancreas is the most common imaging fi nding. Pancreatic ductal obstruction can be caused by calcium-rich, thickened secretions. Other ductal abnormalities include strictures with beaded appearance seen on cholangiopancreatography (Figure 11 ). Complete pancreatic fatty replacement is the most common pancreatic abnormality seen on CT or MRI and is found in 56% to 93% of patients with cystic fi brosis. However, pancreatic fi brosis also may occur. The average age of fatty replacement is 17 years. The imaging appearance varies according to the amount of fat or fi brosis, with fat appearing T1-hyperintense on MRI and hypoattenuating on CT (Figure 12 ). Fibrosis is hypointense on both T1-and T2-weighted MR images.
Complete pancreatic fatty replacement is the most common pancreatic imaging feature seen on CT or MRI in patients with cystic fi brosis.
Lipomatous pseudohypertrophy of the pancreas is a rare disorder associated with cystic fi brosis, but may occur as a distinct entity. 6 The exact etiology is unknown. It is characterized by pancreatic enlargement, fatty replacement of exocrine tissue, and preservation of the ducts and islets.
The differential diagnosis of pancreatic fatty replacement also includes Shwachman-Diamond syndrome, obesity, diabetes, and age-related fatty infi ltration.
Shwachman-Diamond syndrome is the second most common cause of inherited pancreatic insuffi ciency after cystic fi brosis. It is a rare autosomal recessive disorder caused by a mutation in the Schwachman-Diamond-Bodian gene on chromosome 7. It is characterized by exocrine pancreatic insuffi ciency (similar to cystic fi brosis), cytopenias, and skeletal abnormalities such as metaphyseal dysostosis (Figure 13 ).
Pancreatic cysts are relatively common in patients with cystic fi brosis, but pancreatic replacement by cysts greater than 1 cm, as seen in pancreatic cystosis, is a rare manifestation of cystic fi brosis-related pancreatic disease (Figures 14  and 15 ). The etiology may relate to ductal dilatation resulting from blockage by abnormally concentrated pancreatic secretions. 7 The differential diagnosis of pancreatic cystosis includes identifi cation, and appropriate therapy can improve the overall life expectancy and quality of life of affected patients.
von Hippel-Lindau disease, polycystic kidney disease, and lymphatic malformations.
Hepatic Manifestations
The onset of liver disease in patients with cystic fi brosis is usually in early childhood. Hepatic steatosis presents as an echogenic liver on ultrasound and demonstrates decreased parenchymal attenuation on CT (Figure 16 ). Focal biliary cirrhosis occurs in 40% of patients with hepatic involvement, with 1% progressing to end-stage liver disease. In hepatic cirrhosis, the liver appears nodular with splenomegaly, portal vein enlargement, and varices seen in the setting of portal hypertension. Biliary involvement in patients with cystic fi brosis includes microgallbladder, cholelithiasis, gallbladder wall thickening and contraction, and involvement of intra-and extrahepatic bile ducts.
Conclusion
Radiography is the core diagnostic and staging imaging examination tools used in the evaluation of patients with cystic fi brosis. Given that these patients will likely require multiple imaging studies as their disease progresses, one has to be mindful of the amount of ionizing radiation used in this pediatric population. This CME activity emphasizes that with thorough understanding of this multisystem disease, early 
